Akira Yamamoto - Search Results

Year	Number of Results
2002	22
2003	20
2004	17
2005	23
2006	32
2007	21
2008	28
2009	15
2010	25
2011	24
2012	19
2013	30
2014	38
2015	35
2016	39
2017	30
2018	47
2019	40
2020	48
2021	48
2022	1

1

Lymphocyte-C-reactive Protein Ratio as Promising New Marker for Predicting Surgical and Oncological Outcomes in Colorectal Cancer.

Okugawa Y, Toiyama Y, Yamamoto A, Shigemori T, Ide S, Kitajima T, Fujikawa H, Yasuda H, Hiro J, Yoshiyama S, Yokoe T, Saigusa S, Tanaka K, Shirai Y, Kobayashi M, Ohi M, Araki T, McMillan DC, Miki C, Goel A, Kusunoki M. Okugawa Y, et al. Among authors: yamamoto a. Ann Surg. 2020 Aug;272(2):342-351. doi: 10.1097/SLA.0000000000003239. Ann Surg. 2020. PMID: 32675548

2

Primary prevention of cardiovascular disease with pravastatin in Japan (MEGA Study): a prospective randomised controlled trial.

Nakamura H, Arakawa K, Itakura H, Kitabatake A, Goto Y, Toyota T, Nakaya N, Nishimoto S, Muranaka M, Yamamoto A, Mizuno K, Ohashi Y; MEGA Study Group. Nakamura H, et al. Among authors: yamamoto a. Lancet. 2006 Sep 30;368(9542):1155-63. doi: 10.1016/S0140-6736(06)69472-5. Lancet. 2006. PMID: 17011942 Clinical Trial.

3

Mesenteric follicular lymphoma.

Nishimura Y, Yamamoto A, Takahara M, Otsuka F. Nishimura Y, et al. Among authors: yamamoto a. Clin Case Rep. 2019 Apr 12;7(5):1108-1109. doi: 10.1002/ccr3.2148. eCollection 2019 May. Clin Case Rep. 2019. PMID: 31110757 Free PMC article.

4

Diffusion-weighted imaging in prostate cancer.

Tamada T, Ueda Y, Ueno Y, Kojima Y, Kido A, Yamamoto A. Tamada T, et al. Among authors: yamamoto a. MAGMA. 2021 Sep 7. doi: 10.1007/s10334-021-00957-6. Online ahead of print. MAGMA. 2021. PMID: 34491467 Review.

5

Approaches to improve intestinal and transmucosal absorption of peptide and protein drugs.

Yamamoto A, Ukai H, Morishita M, Katsumi H. Yamamoto A, et al. Pharmacol Ther. 2020 Jul;211:107537. doi: 10.1016/j.pharmthera.2020.107537. Epub 2020 Mar 20. Pharmacol Ther. 2020. PMID: 32201316 Review.

6

Diffusion-weighted MRI and its role in prostate cancer.

Tamada T, Sone T, Jo Y, Yamamoto A, Ito K. Tamada T, et al. Among authors: yamamoto a. NMR Biomed. 2014 Jan;27(1):25-38. doi: 10.1002/nbm.2956. Epub 2013 May 27. NMR Biomed. 2014. PMID: 23712781 Review.

7

Bone-Targeted Drug Delivery Systems and Strategies for Treatment of Bone Metastasis.

Katsumi H, Yamashita S, Morishita M, Yamamoto A. Katsumi H, et al. Among authors: yamamoto a. Chem Pharm Bull (Tokyo). 2020;68(7):560-566. doi: 10.1248/cpb.c20-00017. Chem Pharm Bull (Tokyo). 2020. PMID: 32611993 Free article. Review.

8

Intranasal rifampicin for Alzheimer's disease prevention.

Umeda T, Tanaka A, Sakai A, Yamamoto A, Sakane T, Tomiyama T. Umeda T, et al. Among authors: yamamoto a. Alzheimers Dement (N Y). 2018 Jul 14;4:304-313. doi: 10.1016/j.trci.2018.06.012. eCollection 2018. Alzheimers Dement (N Y). 2018. PMID: 30094330 Free PMC article.

9

The biology and management of uveal melanoma.

Sato T, Han F, Yamamoto A. Sato T, et al. Among authors: yamamoto a. Curr Oncol Rep. 2008 Sep;10(5):431-8. doi: 10.1007/s11912-008-0066-z. Curr Oncol Rep. 2008. PMID: 18706273 Review.

10

A uniqe antilipidemic drug--probucol.

Yamamoto A. Yamamoto A. J Atheroscler Thromb. 2008 Dec;15(6):304-5. doi: 10.5551/jat.e621. Epub 2008 Dec 11. J Atheroscler Thromb. 2008. PMID: 19075491 Free article. No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results